Safety and Pharmacokinetic Study of Intranasal 2-DG in Healthy Volunteers

Clinical trial NCT05314933 · COMPLETED

Trial details

NCT number: NCT05314933
Sponsor: G.ST Antivirals GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Nasopharyngitis

Start date: 2022-03-03
Primary completion: 2023-08-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.